Hvidovre

• Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no … Recruiting
  2024-519186-21-01 6 2025-01-30 Staphylococcus aureus bacteremia
• A study to investigate the safety and efficacy of GSK4532990 compared with placebo in adult participants aged 18 to 65 years with alcohol-re … Recruiting
  2024-511596-15-00 4 2024-12-26 Liver Diseases, Alcoholic
• Brachial plexus nerve block for closed reduction of distal radius fracture Recruiting
  2024-512191-35-00 6 2024-12-10 Distal radius fracture in need of acute closed reduction
• An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting
  2024-512113-41-00 5 2024-11-20 Severe Asthma
• Tittle: Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer. A double blinded clinical ran … Recruiting
  2024-518517-26-00 4 2024-10-10 Iron deficiency
• OPTIMAL DIURETIC THERAPIES FOR ACUTE HEART FAILURE WITH VOLUME OVERLOAD Recruiting
  2024-510633-17-00 5 2024-09-05 acute heart failure
• A Phase 2b Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects with Moderately to Severely Active Crohn’s Disease Recruiting
  2023-506704-14-00 4 2024-09-04 Moderately to Severely Active Crohn's Disease
• An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study) Recruiting
  2023-508444-22-01 1 2024-08-26 Chronic hepatitis B infection
• A Study to Evaluate Whether Healing all Bowel Wall Layers is a Superior Treatment Target in Patients with Active Crohn’s Disease (CD). Recruiting
  2023-509096-16-00 6 2024-07-31 Moderately to Severely Active Crohn’s Disease
• Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting
  2024-514900-16-00 6 2024-07-25 Gram-negative Bacteremia
• A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on … Recruiting
  2022-502135-19-00 4 2024-07-18 Calcific Aortic Valve Stenosis
• New treatments to reduce cardiovascular disease in type 1 diabetes Recruiting
  2023-505794-32-04 5 2024-07-05 Type 1 diabetes
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C … Recruiting
  2023-507407-59-00 5 2024-07-04 Chronic Obstructive Pulmonary Disease (COPD)
• COMBAT-ARF Recruiting
  2024-512641-16-00 4 2024-04-15 Infectious pulmonary endotheliopathy
• FIT-HF - Effect of weight loss on physical and cardiac performance in patients with heart failure and obesity Recruiting
  2023-503753-35-01 4 2024-03-20 Obesity and Heart Failure with reduced Ejection Fracition
• SAVE- oral antibiotics for treatment of vertebral osteomyelitis Recruiting
  2023-507617-96-01 6 2024-02-14 Pyogenic vertebral osteomyelitis
• The OPTIMIST study Recruiting
  2023-505940-20-00 11 2023-09-26 osteoporosis
• VASODILATATION OR LOOP-DIURETICS FOR INITIAL TREATMENT OF PULMONARY CONGESTION DUE TO ACUTE HEART FAILURE – A RANDOMIZED PLACEBO-CONTROLLED … Recruiting
  2022-500035-36-01 6 2023-09-14 Acute heart failure with pulmonary congestion
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma … Recruiting
  2022-501943-34-00 5 2023-06-27 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
• HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibod … Recruiting
  2023-504661-23-00 5 2023-06-27 Antiphospholipid antibodies
• Does Tranexamic acid, a medicine used in treating and preventing bleeding problems, reduce the blood loos when it is injected directly into … Recruiting
  2024-517398-26-01 4 2022-10-18 Osteoarthritis
• Pancreatitis and early omega-3-fatty acid infusion for reduction of organ failure and mortality. Recruiting
  2023-505220-57-03 5 2022-05-09 Predicted severe acute pancreatitis
• Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) Recruiting
  2023-508105-24-00 5 2021-11-11 COVID-19
• Mesalamine administration to prevent development of colorectal cancer in Lynch syndrome Recruiting
  2024-514765-19-01 4 2021-08-12 Lynch syndrome, which is increasing the risk of developing colorectal

Showing 49–72 of 132 trials